Obesidad, diabetes y trasplante

Le résumé fourni par la source

Renal transplantation is the best therapeutic option in terms of survival and quality of life for patients with chronic kidney disease. The transplanted patients are becoming older and with more pluripatologia associated. Advances in immunosuppression and in treatment have caused the transplanted patients to die with the functioning renal graft. There is a 10% weight gain during the first year of transplantation, obesity is related to the onset of post-transplant diabetes mellitus. In order to analyze the incidence of obesity and related risk factors in a cohort of renal transplant patients, we conducted an observational and prospective study of these patients, from January 2014 to March 2015, with a 1-year follow-up. As a result, the groups are homogeneous in sex, time in renal replacement therapy but different in age. After 3 months, patients with a body mass index greater than 25 had a higher incidence of post-transplant diabetes mellitus than the group of patients with a body mass index below 25.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.